Give me a sign, any sign

The most recently developed tests that have had this sort of impact in lung cancer are positron emission tomographic imaging, 1 advances in diagnostic bronchoscopy (electromagnetic navigation, 2 endobronchial ultrasound 3 ) and perhaps epidermal growth factor receptor analysis. 4 Progress is occurri...

Full description

Saved in:
Bibliographic Details
Published inThorax Vol. 64; no. 9; pp. 737 - 738
Main Author Mazzone, Peter J
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group LTD 01.09.2009
Subjects
Biomarkers, Tumor - analysis
Breath Tests - instrumentation
DNA methylation
Humans
Lung cancer
Lung Neoplasms - diagnosis
Lung Neoplasms - therapy
Medical imaging
Medical research
Patients
Studies
Ultrasonic imaging
Volatile Organic Compounds - analysis
Volumetric analysis
Online AccessGet full text

Cover

More Information
Summary:The most recently developed tests that have had this sort of impact in lung cancer are positron emission tomographic imaging, 1 advances in diagnostic bronchoscopy (electromagnetic navigation, 2 endobronchial ultrasound 3 ) and perhaps epidermal growth factor receptor analysis. 4 Progress is occurring on many fronts in lung cancer testing. Several lines of evidence suggest that the biochemical processes of lung cancer cells differ from those of normal cells. [...]it is reasonable to expect that the pattern of exhaled volatile compounds in patients with lung cancer would be different from that of individuals without lung cancer.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:0040-6376
1468-3296
DOI:10.1136/thx.2008.107409